Embrey
David G. Embrey, Puyallup, WA US
Patent application number | Description | Published |
---|---|---|
20140128939 | FUNCTIONAL ELECTRICAL STIMULATION (FES) METHOD AND SYSTEM TO IMPROVE WALKING AND OTHER LOCOMOTION FUNCTIONS - A method and system which provides wireless, noninvasive electrical stimulation to different muscle groups to allow the user to conduct physical activities, such as walking, by stimulating various muscle groups in the body at the correct times of activation or by stimulating muscle groups in a simulation mode when standing, sitting or lying down, whereby walking is not required to stimulate the various muscle groups. The system provides a small portable wearable system which utilizes available software, including Bluetooth technology, to provide electrical nerve stimulating pulses with low current, minimal phase charge which is controlled remotely and induce desired muscle contraction with increased comfort for the user. The present method and system applies electrical stimulation with accurate timing, based on a three-dimensional motion sensor, as a trigger to initiate stimulation and which is adapted to turn itself on and off when not walking. | 05-08-2014 |
Janet M. Embrey, Fallston, MD US
Patent application number | Description | Published |
---|---|---|
20080309289 | Temperature and polarization voltage compensation system - A control module for a battery that powers a load includes a compensation module that adjusts a shutoff voltage based on voltage and impedance of the battery and current drawn by the load from the battery as time the load is drawing current increases. A discharge control module restricts power to the load based on the adjusted shutoff voltage. | 12-18-2008 |
Jeffrey R. Embrey, Irving, TX US
Patent application number | Description | Published |
---|---|---|
20120206448 | SYSTEM AND METHOD FOR MODELING A BIOPSY SPECIMEN - The present disclosure provides, in certain embodiments, a system and method for generating a 3D model of a biopsy specimen. The 3D model may greatly enhance the capability to identify insufficient margins surrounding neoplastic tissue obtained through an excisional biopsy, and improve communication from a pathologist back to a surgeon and/or patient. The model provides a 3D representation of the neoplastic tissue within the specimen, thereby allowing the surgeon (or other medical personnel) to rotate and orient the model at any desired angle to identify insufficient margins and relate the location of the insufficient margins to the removal site to more accurately identify the location at which additional tissue needs to be excised. By identifying the exact location at which additional tissue needs to be excised, the surgeon is able to minimize the amount of additional tissue removed from the patient in order to achieve sufficient margins. | 08-16-2012 |
Justin Embrey, Morton, IL US
Patent application number | Description | Published |
---|---|---|
20150069025 | MACHINE COMPONENT CLADDING STRATEGY - Cladding and remanufacturing a machine component includes directing cleaning and welding beams split from an incident laser beam toward the machine component, and moving the machine component relative the cleaning and welding beams such that the welding beam trails behind the cleaning beam along a common travel path. A surface of the machine component is decontaminated by the cleaning beam, whilst a cladding material is melted via the welding beam such that upon solidifying the cladding material forms a coating metallurgically bonded to base material and previously deposited cladding material of the machine component. | 03-12-2015 |
Justin Curtis Embrey, Morton, IL US
Patent application number | Description | Published |
---|---|---|
20140140835 | COMPONENT WITH CLADDING SURFACE AND METHOD OF APPLYING SAME - A slurry pump component includes a base member with a cladding surface. The cladding surface includes a brazing alloy inner layer, a ductile intermediate layer and a wear resistant outer layer. | 05-22-2014 |
20140140836 | COMPONENT WITH CLADDING SURFACE AND METHOD OF APPLYING SAME - A slurry pump component is disclosed. The slurry pump component may have a base member fabricated from white iron, and a cladding surface made of a wear resistant material disposed in a tool steel matrix on the base member. The wear resistant material may have a melting point of greater than about 3000° C. | 05-22-2014 |
20140287165 | CLADDING COMPOSITION WITH FLUX PARTICLES - The present disclosure is related to a cladding composition. The cladding composition may include cladding powder particles and flux particles. The flux particles may have an average particle size of less than about 40 μm, and more than about 50% of the flux particles may adhere to the surfaces of the cladding powder particles. | 09-25-2014 |
Justin Curtis Embrey, Mortin, IL US
Patent application number | Description | Published |
---|---|---|
20140141930 | PLANET CARRIER SALVAGE PROCESS - A remanufactured planet carrier is disclosed having a first plate and a second plate spaced apart from and oriented generally parallel to the first plate. Supports join and support the first and second plates. The remanufactured planet carrier further has a plurality of first pin bores in the first plate and a plurality of second pin bores in the second plate. The first pin bores are parallel and generally aligned with the second pin bores. A cylindrical member extends from a central axis of the second plate away from the first plate with a shaft bore formed within the cylindrical member. The first and second pin bores and the shaft bore each have a surface layer with a hardness of at least about 180 BHN and a strength of at least about 500 MPa. | 05-22-2014 |
Mark Embrey, Harleysville, PA US
Patent application number | Description | Published |
---|---|---|
20080287394 | Hiv Integrase Inhibitors - Hydroxy-substituted pyrazinopyrrolopyridazine dione compounds are inhibitors of HIV integrase and inhibitors of HIV replication. In one embodiment, the dione compounds are of Formula (I) wherein R | 11-20-2008 |
Mark W. Embrey, Harleysville, PA US
Patent application number | Description | Published |
---|---|---|
20100056516 | 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS - 1-Hydroxy naphthyridine compounds (e.g., 1-hydroxy naphthyridin-2(1H)-one compounds of Formula I are inhibitors of HIV integrase and/or HIV RNase H and inhibitors of HIV replication: (I) wherein X and R1-R6 are as defined herein. The compounds are useful in the prophylaxis and treatment of infection by HIV and in the prophylaxis, delay in the onset, and treatment of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other anti-HIV agents such as HIV antivirals, immunomodulators, antibiotics and vaccines. | 03-04-2010 |
20100087419 | HIV INTEGRASE INHIBITORS - Compounds of Formula I are inhibitors of HIV integrase and inhibitors of HIV replication: | 04-08-2010 |
20120022045 | BRIDGED COMPOUNDS AS HIV INTEGRASE INHIBITORS - Compounds of Formula I are inhibitors of HIV integrase and inhibitors of HIV replication: the asterisk * in Q denotes the point of attachment to the rest of the compound; and n, L1, L2, X | 01-26-2012 |
20130338141 | HIV INTEGRASE INHIBITORS - Compounds of Formula I are inhibitors of HIV integrase and inhibitors of HIV replication: | 12-19-2013 |
Shawna K. Embrey, Indianapolis, IN US
Patent application number | Description | Published |
---|---|---|
20120064542 | MONOCLONAL ANTIBODIES AND DETECTION METHODS FOR ENZYMES THAT CONFER RESISTANCE TO 2,4-DICHLOROPHENOXYACETIC ACID - Described herein are monoclonal antibodies and methods useful for determining and quantitating the presence of AAD-1 (aryloxyalkanoate dioxygenase) enzyme. These monoclonal antibodies are surprisingly well suited for detecting AAD-1 transgenic event gene products in a variety of plants and plant tissues. The invention further provides quantitative and qualitative immunoassays using the immunoglobulins of the invention. | 03-15-2012 |